Is a complete CRMD research report available?

No complete published report is available for CorMedix Inc. (CRMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CorMedix Inc. (CRMD)

NASDAQ: CRMD · USD

$8.20

+0.20 (+2.4%)· Recorded snapshot

Market cap	638.8M
Revenue (ttm)	462.2M
Net income (ttm)	186M
EPS (ttm)	$2.08
Shares out	77.9M
P/E (trailing)	3.9x
Volume	1,005,735
Beta	1.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 462.2M
Net income (ttm): 186M
EPS (ttm): $2.08
P/E (trailing): 3.9x
Market cap: 638.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001410098
Company name	CorMedix Inc.
Country	United States
Country code	US
CUSIP number	21900C308
Earnings date	2026-11-11
Earnings time	bmo
Employees	191
Employees change	126
Employees growth	193.85%
Enterprise value	$529.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2010-03-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US21900C3088
Last 10-K release date	2026-03-05
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2019-03-26
Last stock split type	Reverse
Market cap	$638.8M
Market cap category	Small-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$8.20
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CRMD
U.S. state	New Jersey
Website	https://cormedix.com

Metric

Value

Amount currency

USD

CIK code

0001410098

Company name

CorMedix Inc.

Country

United States

Country code

CUSIP number

21900C308

Earnings date

2026-11-11

Earnings time

bmo

Employees

191

Employees change

126

Employees growth

193.85%

Enterprise value

$529.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2010-03-25

Is primary listing

Yes

Is SPAC

ISIN number

US21900C3088

Last 10-K release date

2026-03-05

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2019-03-26

Last stock split type

Reverse

Market cap

$638.8M

Market cap category

Small-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$8.20

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CRMD

U.S. state

New Jersey

Website

https://cormedix.com

Metric	Value
Earnings yield	25.42%
EV/Earnings	2.79x
EV/EBIT	2.28x
EV/EBITDA	1.97x
EV/FCF	2.07x
EV/Sales	1.12x
FCF / EV yield	48.32%
FCF yield	39.91%
Forward EV/Sales	2.1x
Forward P/S	2.54x
Graham number	16.67616
Graham upside	107.16%
P/(FCF - SBC) ratio	2.68x
P/(OCF - SBC) ratio	2.64x
P/B ratio	1.35x
P/E ratio	3.93x
P/FCF ratio	2.51x
P/OCF ratio	2.47x
P/S ratio	1.36x
Price / tangible book value	8.67x
Price/EBITDA ratio	2.39x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

25.42%

EV/Earnings

2.79x

EV/EBIT

2.28x

EV/EBITDA

1.97x

EV/FCF

2.07x

EV/Sales

1.12x

FCF / EV yield

48.32%

FCF yield

39.91%

Forward EV/Sales

2.1x

Forward P/S

2.54x

Graham number

16.67616

Graham upside

107.16%

P/(FCF - SBC) ratio

2.68x

P/(OCF - SBC) ratio

2.64x

P/B ratio

1.35x

P/E ratio

3.93x

P/FCF ratio

2.51x

P/OCF ratio

2.47x

P/S ratio

1.36x

Price / tangible book value

8.67x

Price/EBITDA ratio

2.39x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	49.16%
EBITDA margin	56.8%
Effective tax rate	7.98%
FCF margin	54.17%
Gross margin	90.21%
Operating margin	49.16%
Pretax margin	44%
Profit margin	40.49%
Profit per employee	$973,901
Profitable quarters	7
Profitable years	1
Revenue per employee	$2.4M
ROA	24.56%
ROA (5Y)	-19.1%
ROCE	31.71%
ROE	54.93%
ROE (5Y)	-26.75%
ROIC	55.18%
SBC / revenue	3.53%
Tax / revenue	3.51%

Metric

Value

EBIT margin

49.16%

EBITDA margin

56.8%

Effective tax rate

7.98%

FCF margin

54.17%

Gross margin

90.21%

Operating margin

49.16%

Pretax margin

44%

Profit margin

40.49%

Profit per employee

$973,901

Profitable quarters

Profitable years

Revenue per employee

$2.4M

ROA

24.56%

ROA (5Y)

-19.1%

ROCE

31.71%

ROE

54.93%

ROE (5Y)

-26.75%

ROIC

55.18%

SBC / revenue

3.53%

Tax / revenue

3.51%

Metric	Value
EPS growth	163.53%
EPS growth (Q)	6.66%
EPS growth (QoQ)	-31.37%
EPS growth quarters	2
EPS growth years	2
FCF growth	723.5%
FCF growth (Q)	185.9%
FCF growth (QoQ)	105.69%
Gross profit growth	258.18%
Gross profit growth (Q)	130.52%
Gross profit growth 3Y	2,191.77%
Gross profit growth 5Y	564.14%
Net income growth	265.86%
Net income growth (Q)	31.07%
Net income growth (QoQ)	-33.1%
Net income growth quarters	8
Net income growth years	2
OCF growth	733.59%
OCF growth (Q)	187.54%
OCF growth (QoQ)	103.48%
Operating income growth	360.76%
Operating income growth (Q)	119.56%
Revenue growth	280.5%
Revenue growth (Q)	156.52%
Revenue growth (QoQ)	-20.01%
Revenue growth 10Y	128.95%
Revenue growth 3Y	2,230.52%
Revenue growth 5Y	351.94%
Revenue growth quarters	5
Revenue growth years	1

Metric

Value

EPS growth

163.53%

EPS growth (Q)

6.66%

EPS growth (QoQ)

-31.37%

EPS growth quarters

EPS growth years

FCF growth

723.5%

FCF growth (Q)

185.9%

FCF growth (QoQ)

105.69%

Gross profit growth

258.18%

Gross profit growth (Q)

130.52%

Gross profit growth 3Y

2,191.77%

Gross profit growth 5Y

564.14%

Net income growth

265.86%

Net income growth (Q)

31.07%

Net income growth (QoQ)

-33.1%

Net income growth quarters

Net income growth years

OCF growth

733.59%

OCF growth (Q)

187.54%

OCF growth (QoQ)

103.48%

Operating income growth

360.76%

Operating income growth (Q)

119.56%

Revenue growth

280.5%

Revenue growth (Q)

156.52%

Revenue growth (QoQ)

-20.01%

Revenue growth 10Y

128.95%

Revenue growth 3Y

2,230.52%

Revenue growth 5Y

351.94%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3.5M
Depreciation and amortization	$35.3M
EBIT	$227.2M
EBITDA	$262.5M
EPS	$2.08
FCF per share	$3.21
Financing cash flow	$129.9M
Free cash flow	$250.4M
Free cash flow minus SBC	$234.1M
Gross profit	$417M
Income taxes	$16.2M
Investing cash flow	$-285.6M
Net borrowing	$149.5M
Net cash flow	$98.3M
Net income	$186M
Operating cash flow minus SBC	$237.6M
Operating income	$227.2M
Revenue	$462.2M
Stock-based compensation	$16.3M

Metric

Value

Capital expenditures

$-3.5M

Depreciation and amortization

$35.3M

EBIT

$227.2M

EBITDA

$262.5M

EPS

$2.08

FCF per share

$3.21

Financing cash flow

$129.9M

Free cash flow

$250.4M

Free cash flow minus SBC

$234.1M

Gross profit

$417M

Income taxes

$16.2M

Investing cash flow

$-285.6M

Net borrowing

$149.5M

Net cash flow

$98.3M

Net income

$186M

Operating cash flow minus SBC

$237.6M

Operating income

$227.2M

Revenue

$462.2M

Stock-based compensation

$16.3M

Metric	Value
Altman Z-Score	2.57
Book value per share	$5.93
Debt / EBITDA	0.56
Debt / equity	0.32
Debt / FCF	0.59
Goodwill	$30M
Interest coverage	81.68
Long-term assets	$423.5M
Long-term liabilities	$255.8M
Net cash (debt)	$109.2M
Net cash / market cap	17.41%
Net cash growth	-42.59%
Net debt / EBITDA	-0.42
Net debt / equity	-0.24
Net debt / FCF	-0.44
Piotroski F-Score	5
Property, plant and equipment	$7.9M
Shareholders' equity	$460.8M
Tangible book value	$72.4M
Tangible book value per share	$0.93
Total assets	$904.1M
Total cash	$256.7M
Total debt	$147.5M
Total liabilities	$443.2M
WACC	10.03%

Metric

Value

Altman Z-Score

2.57

Book value per share

$5.93

Debt / EBITDA

0.56

Debt / equity

0.32

Debt / FCF

0.59

Goodwill

$30M

Interest coverage

81.68

Long-term assets

$423.5M

Long-term liabilities

$255.8M

Net cash (debt)

$109.2M

Net cash / market cap

17.41%

Net cash growth

-42.59%

Net debt / EBITDA

-0.42

Net debt / equity

-0.24

Net debt / FCF

-0.44

Piotroski F-Score

Property, plant and equipment

$7.9M

Shareholders' equity

$460.8M

Tangible book value

$72.4M

Tangible book value per share

$0.93

Total assets

$904.1M

Total cash

$256.7M

Total debt

$147.5M

Total liabilities

$443.2M

WACC

10.03%

Metric	Value
Asset turnover	0.8
Current assets	$480.6M
Current liabilities	$187.4M
Current ratio	2.56
Inventory turnover	1.88
Net working capital	$36.5M
Quick ratio	2.23
Working capital	$293.2M
Working capital turnover	1.81

Metric

Value

Asset turnover

0.8

Current assets

$480.6M

Current liabilities

$187.4M

Current ratio

2.56

Inventory turnover

1.88

Net working capital

$36.5M

Quick ratio

2.23

Working capital

$293.2M

Working capital turnover

1.81

Metric	Value
Buyback yield / dilution	-40.04%
Dividend yield	0%
Shareholder yield	-40.04%

Metric

Value

Buyback yield / dilution

-40.04%

Dividend yield

Shareholder yield

-40.04%

Metric	Value
10Y price change	-22.51%
10Y return CAGR	-2.52%
10Y total return	-22.51%
150-day SMA	$7.87
15Y price change	410.94%
15Y return CAGR	11.49%
15Y total return	410.94%
1D price change	2.44%
1M price change	4.14%
1M total return	4.14%
1W price change	7.99%
1W total return	7.99%
1Y price change	-26.02%
1Y return CAGR	-26.03%
1Y total return	-26.02%
20-day SMA	$7.55
200-day SMA	$7.68
3M price change	7.57%
3M total return	7.57%
3Y price change	172.5%
3Y return CAGR	39.67%
3Y total return	172.5%
50-day SMA	$7.87
50-day SMA vs 200-day SMA	50over200
52-week high	$13.02
52-week high date	2025-12-30
52-week low	$6.13
52-week low date	2026-03-06
5Y price change	65.49%
5Y return CAGR	10.6%
5Y total return	65.49%
6M price change	4.54%
6M total return	4.54%
All-time high	$52.00
All-time high date	2015-04-01
All-time low	$0.73
All-time low date	2012-06-15
Average true range (ATR)	$0.28
Average volume	1.1M
Beta (1Y)	0.84
Beta (2Y)	1.19
Beta (5Y)	1.41
Change from 52-week high	-37.06%
Change from 52-week low	33.8%
Change from all-time high	-84.28%
Change from all-time low	1,022.17%
Change from open	2.82%
Day's gap	-0.38%
Dollar volume	$8.2M
High price	$8.21
Low price	$7.91
Monthly RSI	49.58
Open price	$7.97
Position in 52-week range	95%
Premarket change	0%
Premarket close	$8.00
Premarket price	$8.00
Premarket volume	988
Previous close	$8.00
Price vs 150-day SMA	3.9%
Price vs 20-day SMA	8.35%
Price vs 200-day SMA	6.5%
Price vs 50-day SMA	3.93%
Relative volume	0.9
RSI	63.24
Sharpe ratio	-0.28
Sharpe ratio (3Y)	0.75
Sharpe ratio (5Y)	0.5
Sortino ratio	-0.25
Sortino ratio (3Y)	1.24
Sortino ratio (5Y)	0.8
Volume	1M
Weekly RSI	52.43
YTD price change	-29.71%
YTD total return	-29.71%

Metric

Value

10Y price change

-22.51%

10Y return CAGR

-2.52%

10Y total return

-22.51%

150-day SMA

$7.87

15Y price change

410.94%

15Y return CAGR

11.49%

15Y total return

410.94%

1D price change

2.44%

1M price change

4.14%

1M total return

4.14%

1W price change

7.99%

1W total return

7.99%

1Y price change

-26.02%

1Y return CAGR

-26.03%

1Y total return

-26.02%

20-day SMA

$7.55

200-day SMA

$7.68

3M price change

7.57%

3M total return

7.57%

3Y price change

172.5%

3Y return CAGR

39.67%

3Y total return

172.5%

50-day SMA

$7.87

50-day SMA vs 200-day SMA

50over200

52-week high

$13.02

52-week high date

2025-12-30

52-week low

$6.13

52-week low date

2026-03-06

5Y price change

65.49%

5Y return CAGR

10.6%

5Y total return

65.49%

6M price change

4.54%

6M total return

4.54%

All-time high

$52.00

All-time high date

2015-04-01

All-time low

$0.73

All-time low date

2012-06-15

Average true range (ATR)

$0.28

Average volume

1.1M

Beta (1Y)

0.84

Beta (2Y)

1.19

Beta (5Y)

1.41

Change from 52-week high

-37.06%

Change from 52-week low

33.8%

Change from all-time high

-84.28%

Change from all-time low

1,022.17%

Change from open

2.82%

Day's gap

-0.38%

Dollar volume

$8.2M

High price

$8.21

Low price

$7.91

Monthly RSI

49.58

Open price

$7.97

Position in 52-week range

95%

Premarket change

Premarket close

$8.00

Premarket price

$8.00

Premarket volume

988

Previous close

$8.00

Price vs 150-day SMA

3.9%

Price vs 20-day SMA

8.35%

Price vs 200-day SMA

6.5%

Price vs 50-day SMA

3.93%

Relative volume

0.9

RSI

63.24

Sharpe ratio

-0.28

Sharpe ratio (3Y)

0.75

Sharpe ratio (5Y)

0.5

Sortino ratio

-0.25

Sortino ratio (3Y)

1.24

Sortino ratio (5Y)

0.8

Volume

Weekly RSI

52.43

YTD price change

-29.71%

YTD total return

-29.71%

Metric	Value
Float	65.9M
Float percentage	84.53%
Shares change (QoQ)	-0.54%
Shares change (YoY)	40.04%
Shares held by insiders	7.42%
Shares held by institutions	49.03%
Shares outstanding	77.9M
Short % of float	23.41%
Short % of shares	19.79%
Short ratio	18 days

Metric

Value

Float

65.9M

Float percentage

84.53%

Shares change (QoQ)

-0.54%

Shares change (YoY)

40.04%

Shares held by insiders

7.42%

Shares held by institutions

49.03%

Shares outstanding

77.9M

Short % of float

23.41%

Short % of shares

19.79%

Short ratio

18 days

CorMedix Inc. (CRMD)

Price

Financial snapshot

Fair-value bridge

Latest news · CRMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CRMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CRMD

Frequently asked questions